Prolactin secretion in patients with acute renal failure

Area of Science:

• Endocrinology
• Nephrology
• Biochemistry

Background:

• Acute renal failure (ARF) is a complex condition affecting multiple physiological systems.
• Alterations in hormone levels, including prolactin, are observed in patients with ARF.
• The precise mechanisms regulating prolactin in ARF remain incompletely understood.

Purpose of the Study:

• To investigate basal and stimulated serum prolactin levels in patients with ARF.
• To assess the impact of chloropromazine stimulation and alfa-bromocriptine inhibition on prolactin dynamics in ARF.
• To elucidate the contribution of hypersecretion and impaired biodegradation to hyperprolactinemia in ARF.

Main Methods:

• Serum prolactin levels were measured in 44 ARF patients and controls.
• Chloropromazine was used as a stimulant for prolactin secretion.
• Alfa-bromocriptine was administered to assess prolactin half-life and inhibition.
• Patients were categorized into oliguric and polyuric groups.

Main Results:

• Significantly elevated basal serum prolactin levels were observed in both oliguric and polyuric ARF patients.
• Intramuscular chloropromazine administration markedly increased serum prolactin concentrations in ARF patients.
• The apparent half-life of prolactin was moderately longer in ARF patients compared to normal individuals after alfa-bromocriptine administration.

Conclusions:

• Hyperprolactinemia in ARF is primarily attributed to increased prolactin secretion and, to a lesser extent, impaired renal biodegradation.
• Prolactin secretion in ARF patients demonstrates hyperresponsiveness to intramuscular chloropromazine.
• These findings suggest a dysregulation of prolactin homeostasis in the context of acute renal failure.